TP53 and neoplasm: It is also interesting to note that stage IV tumours had a slightly higher frequency (20/26, 76.9%) of Pro allele loss than stage I–III tumours (11/19, 57.9%) (P=0.17 by χ2) regardless of p53 mutation.